Artera expands patient communications platform support to additional
The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.
Related Articles
Bile acid synthesis impedes tumor-specific T cell responses during liver cancer
The metabolic landscape of cancer greatly influences antitumor immunity, yet it remains unclear how organ-specific metabolites in the tumor microenvironment influence immunosurveillance. We found that…
Robots set to move beyond factory as AI advances
Today’s robots perform safety checks at industrial plants, conduct quality control in manufacturing, and are even starting to keep hospital patients company.
Compact quantum light processing
An international collaboration of researchers has achieved a significant breakthrough in quantum technology, with the successful demonstration of quantum interference among several single photons using…
Why Tesla And NVIDIA Are Taking Different Paths To Train AI Systems
At this year’s Consumer Electronics Show in Las Vegas, NVidia just announced the launch of its Cosmos platform, designed to accelerate the development of physical…
JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts
EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived 51% during 2024, to 92 from 186…
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging.
Inha University Hospital eyes Stage 7 EMRAM
The hospital east of South Korea’s capital Seoul largely serves international patients who require global quality care. CEO Tack Lee discusses.
J&J to Acquire Intra-Cellular for $14.6B
Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.
Why the ‘Ferrari of viruses’ is surging through the Northern Hemisphere
Norovirus, which causes explosive diarrhea and vomiting, may be on the rise because of an antibody-dodging variant and post–COVID-19 socializing
